Showing posts with label Osage Partners. Show all posts
Showing posts with label Osage Partners. Show all posts

InstaMed: Another $15 million raised; total now $77 million, according to Crunchbase





Tom Paine



 Subscribe in a reader
Subscribe to Philadelphia Tech News by Email



InstaMed, the Philadelphia-based healthcare payments platform, has raises another $15 million, the company announced yesterday.

I haven't keep count of all their financing events, but Crunchbase (which isn't always completely accurate), puts InstaMed's total raised now at $77.2 million in 15 rounds from 5 investors. As has been the case recently, InstaMed didn't name investors in this round, only to say that existing and new investors were in it. InstaMed says it is supported by a broad investor base, including four funds and four publicly traded companies. Osage Partners and Ashby Point Capital are two of them. Josh Kopelman was an early investor, as an individual. InstaMed only said that it "will deploy the new capital to meet the increasing demands of healthcare consumerism."

InstaMed says it proceesses more than $10 billion in healthcare payments a year. Earlier this year it launched a mobile app, InstaMed Go. Bill Marvin is InstaMed's CEO, and its
executive ranks and investor group have a heavy Penn orientation.

InstaMed calls Philadelphia its headquarters, and has another major office in Newport Beach. There are 108 InstaMed employees on LinkedIn, including 72 in Philadelphia.





NJEN Panel Discusses “Where’s the Money?” Alternative Financing for Tech Companies, Part 2



Esther Surden
Publisher & Editor, NJTechWeekly.com

(NJTechWeekly.com is continuing to catch up on pre-Sandy coverage that would have been published in early November but was postponed because of post-storm chaos and the volume of Sandy-related stories. We apologize for the delay.)



While it was often difficult for the N.J. tech community to obtain funding in 2012, there were a variety of alternative options for companies, according to panelists at an October 10, 2012, New Jersey Entrepreneurial Network (NJEN) event in Princeton.

Some 60 attendees heard about crowdfunding, bank financing, a myriad of tools available from the state of N.J. and even a funding vehicle that gives immigrants green cards while providing financing to companies that create jobs.

New Jersey Economic Development Authority (EDA) director of technology and life sciences Kathleen Coviello’s presentation on ways the EDA can help tech companies was extremely comprehensive and demonstrated the agency’s view of its relationship with the state.

“Our role is to function as the bank for the state. We have money. As the bank for the state, we have underwriting standards we have to meet and due diligence we have to go through. Particularly in this tough economic environment, we have a fiduciary responsibility and must be fiscally prudent. We are not throwing money out the door,” Coviello said. However, she added, “we are doing transactions.”

EDA transactions made prior to the October meeting include providing $3.3 million to Fluitec, a Belgian company that had relocated to the U.S. and wanted to develop a manufacturing facility in northern N.J.

“This is one of the most attractive programs we have,” Coviello said, referring to financing through the Edison Innovation Clean Energy Manufacturing Fund, funded by the N.J. Board of Public Utilities and administered by the EDA. Companies can get up to $1.3 million in grant and the remainder in very low-interest loans if they meet certain performance metrics,” she noted. “We get funding for this from a sister agency formed to help promote clean technologies in the state of N.J.”

“We also just closed a transaction for FieldView Solutions (Edison), a company that has received funding through the Edison Innovation Green Growth Fund. “We provided that company with a million-dollar loan and, again, if they hit performance metrics, half of it gets converted into a grant.” (NJTechWeekly.com profiled FieldView Solutions here.)

Another approved company, Phone.com (Newark), “provides phone services to small and medium-sized businesses throughout the state. The company was virtual at the time and already had a little bit of VC funding. We provided matching money to that VC money in the form of a loan with warrants. And the company is going to relocate to the NJIT EDC [New Jersey Institute of Technology Enterprise Development Center] and put down roots in New Jersey,” said Coviello.

CareKinesis , a Moorestown company with a healthcare IT business model, has also been helped by the EDA. Its founder, Cal Knowlton, already had a successful business in Pa. but wanted CareKinesis to stay on the Jersey side of the river, where he lived and had grown up. “We provided a matching loan program to some of the VC money he raised,” said Coviello.

She continued, “As the bank for the state, we administer some legislative programs. You may be familiar with the Net Operating Loss Program, which is unique to N.J. I’ve even spoken to the federal government about this, as they are looking to deploy something like it on a national level. Companies that are losing money can sell those losses for cash today.

“We all know as entrepreneurs that cash in hand today is much more important than taking it as a write-off against your future losses. The state says you can sell those losses to profitable N.J. businesses. We set the threshold and ask that the recipient companies demonstrate they are growing jobs in N.J. There are three checkpoints: year one, year three and year five. Companies have to be at 10 jobs by the end of year ten.”

This program has been very helpful to N.J. biotech companies, Coviello said, and it benefits profitable firms by providing them a tax shield. The process involves an annual application that must be received by the end of June.

“In his budget the governor approved a $60 million annual allocation for this program this year [fiscal year 2013],” Coviello said. There is always an oversubscription, she added. “This year we expect the average award to be around $920,000.” [NJTechWeekly.com will be publishing the 2012 list of tech companies that participated in this program.]

“We also administer tax incentives for job growth, so before any of you entrepreneurs think about signing a lease in N.J., see us about a program we have that can incentivize you to grow your jobs in N.J.”

Coviello said the EDA is constantly approached by people who need early-stage capital, but as a bank, the organization doesn’t give out “risky money.” However, the state does invest in venture funds, working with partners and professional managers.

“We are invested across 11 funds currently,” she said. Some of the funds are fully invested, and some have capacity in them. “We take a portfolio approach: we have healthcare, life science, early-stage, and growth venture funds.” The state puts money into the funds as a limited partner and requires the venture partner to match the money the state contributes with a three times multiplier, said Coviello.

“Most recently we announced a $3 million investment in Osage Partners [Bala Cynwyd, Pa.]. Osage had been doing transactions in N.J. on a one-off basis but was located in Pa.” Funds were selected during a competitive application process that evaluated the VC’s activity in N.J. Now Osage has opened an office in N.J., Coviello said, and it has to “turn $3 million into $9 million in early-stage investments” by funding companies with less than $3 million in revenues.

“This approach takes the due diligence process and puts it in professional hands,” she pointed out. “The VCs can offer the coaching and mentoring we can’t,” she added.

The state has also invested $2 million in NextStage Capital (Audubon, Pa.), “which will be turned into $6 million for N.J. entrepreneurs.”

Coviello also spoke about TechLaunch (Montclair), the first N.J. tech accelerator funded by the EDA and which NJTechWeekly.com has covered in depth.

Coviello discussed her organization’s support of biotech through a real estate play. The EDA has purchased a complete campus in New Brunswick from Johnson & Johnson and put in a state-of-the-art wet lab facility close to Rutgers and, geographically, in the heart of the pharmaceutical industry. “We have strategic relationships with Rutgers, so our tenants can use its resources for mentoring and cooperation on animal studies. We are really looking to build that pharma community,” she noted.



Esther Surden is Publisher and Editor of NJTechWeekly, and a contributor to Philly Tech News. This article originally appeared in NJTechWeekly, and was reposted here with her approval.



permalink


InstaMed raises another $14 million




Tom Paine


InstaMed, the heavily UPenn connected (I mean its management & investors, not the school) healthcare payments processing platform based in Philadelphia, has just announced it has raised another $14 million. The press release did not name any investors, but only said that "the new capital included funding from five funds, including one new fund, and angels" and that more than 90% of previous investors participated.

This will bring the total investment in InstaMed to at least $36 million, according to my figures. It last reported a $5.5 million raise late last year. Investors have included Osage Partners, NJTC Venture Fund, US Bancorp, and Ashby Point Capital. Josh Kopelman was an early investor through his personal Midas Capital fund. See my brief writeup on InstaMed from last year.

InstaMed recently said it had surpassed $30 billion in Healthcare Payments Processed, and projects that it will process $20 billion in 2012 alone.



permalink



Philly Tech TidBits 9/8/2011: InstaMed raises another $5.5 million

InstaMed, the Philadelpia-based provider of healthcare payment systems, has raised an additional $5.5 million, according to an SEC Filing. Headed by Founder, President and CEO Bill Marvin, InstaMed raised $6 million in debt and equity one year ago and had prior funding rounds in 2009 ($6 million) and 2007 ($5 milion), so it has now raised at least $22.5 million. Investors have included Osage Partners, NJTC Venture Fund, US Bancorp, and Ashby Point Capital. Josh Kopelman was an early investor through his personal Midas Capital fund.
InstaMed has several Penn/Wharton connections among its management team, board and advisors; Marvin played on the varsity squash team at Penn (as did Comcast's Brian Roberts). Bill was an executive with Accenture’s Health and Life Sciences practice and founded a software company that was acquired by a Microsoft/ Pfizer joint venture.
I don't have any information about InstaMed's financial performance. It describes itself as a healthcare payments network connecting providers, payers and patients, and says it serves over 200,000 providers nationally with tens of billions of dollars in healthcare payments processed.


Speaking of Osage, they have raised $47 million for what appears to be a new private equity fund, Osage Venture Partners III, LP.


UPenn-related MentorTech Ventures has raised $10.75 million towards a $40 million offering for a new fund, MentorTech Ventures III L.P., according to an SEC filing. Though not large, MentorTech, managed by Michael B. Aronson and Boris Kalandar, takes small, usually early stage stakes in Penn-associated ventures; major successes have included Diaper.com (sold to Amazon), PayQuik (sold to Citi), Yodle, and Neat Company. With all of the entrepreneurial activity going on within Penn/Wharton, it should have plenty of opportunities ahead.


Penn Mezzanine LP of Wayne has raised $34.2 million in an offering, according to an SEC filing. Its not clear whether this is related to or completely separate from Safefuard Scientifics' announced acquisition of a 36% interest in Penn Mezzanine in July.
Penn Mezzanine, which was founded in 2010, is headed by Managing Partners Donald K. Rice and Darl A. Petty. It provides mezzanine financing to middle market companies using combinations of structured equity and debt.


Square One Bank has provided a a $2.5 million credit facility to ProfitPoint, Inc., a Clifton Heights-based provider of stored value and loyalty program solutions. NewSpring Ventures was an early investor in ProfitPoint.


Oaks, PA-based asset manager and investment processor SEI Investments teamed up with Greenwich Associates on a survey of institutional investors, consultants and fund managers globally. The first report (out of three installments) from the survey indicated that Private Equity exits were way up in the 2nd quarter, and that fund allocations to that area may increase. But SEI says that many of those exits represent “low hanging fruit” and the average holding period for a portfolio company has lengthened to five years.


Silicon Valley Research Group says it has opened a practice in Philadelphia, its fourth location. Marc Pitcher, the company’s Director of Client Services, is based in Philly. He also manages the firm's New York City practice. "Philadelphia has a burgeoning technology and venture capital scene, and the presence of the University of Pennsylvania, Drexel, Temple and other highly respected centers of innovation make the city a natural fit for our company”, Pitcher said in a statement.



permalink